Articles

Submitted to FDA for Stand-Alone Therapy in Q1 2008, studies show that exenatide can lower A1c 0.7 to 0.9 points as a mono therapy

Novo Nordisk announced headline clinical results from a phase 3 clinical study comparing the effects of liraglutide, a once-daily human GLP-1 analogue, with exenatide, a twice-daily GLP-1 analogue.

Bile acid aberration found in Type 2 diabetes patients and cholic acid has a significantly higher rate.

It may be time to use the A1c to help diagnosis those 6.2 million people that have diabetes and are not aware.

For people with diabetes, high blood pressure poses a special threat, multiplying their risk of heart attacks, strokes and kidney problems. But a new study finds that even when people with diabetes show up in their doctor’s office with a high blood pressure reading, there’s only a 50-50 chance that …

Periodontal Disease is more common in those with diabetes and now we are seeing that it is also increases the risk of cancer.

Strict adherence to a traditional Mediterranean diet yielded an 83% relative reduction in the risk of developing type 2 diabetes, a prospective study found.

Only half of patients had their therapy changed as needed, study found

The benefits of cocoa, known recently for its ability to reduce blood pressure and improve endothelial function, also extends to diabetic patients, a new study has shown.

Welchol (colesevelam Hcl) lowered A1C by a mean 1 percent or greater when added to metformin, insulin, or sulfonylurea-based therapy in 47 percent of patients.